Group One Trading, L.P. Avalo Therapeutics, Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.0 - $10.45 $8,535 - $29,730	-2,845 Reduced 56.41%	2,198 $1,000
Q1 2022 May 12, 2022	SELL	$7.57 - $21.72 $3,361 - $9,643	-444 Reduced 8.09%	5,043 $4,000
Q4 2021 Feb 11, 2022	SELL	$19.68 - $28.68 $50,223 - $73,191	-2,552 Reduced 31.75%	5,487 $9,000
Q3 2021 Nov 12, 2021	BUY	$26.16 - $40.68 $210,300 - $327,026	8,039 New	8,039 $18,000

34.6K

Ticker AVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,414,100
Market Cap $84.9M
Description
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.